NCT06884189 Application of Plant Protection Products (PPP) in Apple Orchards
| NCT ID | NCT06884189 |
| Status | Recruiting |
| Phase | — |
| Sponsor | German Federal Institute for Risk Assessment |
| Condition | Dermal Exposure |
| Study Type | OBSERVATIONAL |
| Enrollment | 16 participants |
| Start Date | 2025-03-11 |
| Primary Completion | 2025-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 16 participants in total. It began in 2025-03-11 with a primary completion date of 2025-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the aPPPle pilot study is to test feasibility and generate first results in preparation for a main study. The aPPPle study will investigate the exposure of operators, workers and residents to plant protection products (PPP) and potential physiological effects on blood biomarkers. The target plants are apple crops, as application occurs at higher altitudes and therefore higher drift/exposure is expected compared to ground-level application. The substances to be investigated are acetamiprid (an insecticide) and dithianon and dodine (two fungicides).
Eligibility Criteria
Inclusion Criteria: * belonging to one of the defined study groups * over 18 years of age at the time of recruitment * person can understand the language and content of the study requirements * person is capable of consenting to participate in the study and has given written consent to participate in the aPPPle study * person has health insurance Exclusion Criteria for residents and control: person has direct professional contact with the tested substances acetamiprid, dithianon or dodine
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06884189 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dermal Exposure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06884189 currently recruiting?
Yes, NCT06884189 is actively recruiting participants. Contact the research team at cornelia.weikert@bfr.bund.de for enrollment information.
Where is the NCT06884189 trial being conducted?
This trial is being conducted at Berlin, Germany.
Who is sponsoring the NCT06884189 clinical trial?
NCT06884189 is sponsored by German Federal Institute for Risk Assessment. The trial plans to enroll 16 participants.